Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis-Reference-Cited by-同舟云学术

Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis

Published:2022-07-14 Issue:11 Volume:107 Page:2725-2731
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Lemoine Sandrine,Mornet Clelia,Quintin-Roue Isabelle,Rousselet Marie-Christine,Cottin Laurane,Georgeais Aurélie,Dubouis Ludovic,Boyer Françoise,Orvain Corentin,Caillon Clara,Renard Maxime,Le Brun Valoris,Le Clech Lenaig,Ianotto Jean-Christophe,Génin Emmanuelle,Burroni Barbara,Ugo Valérie,Paz Damien Luque,Lippert Eric

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference12 articles.

1. Arber DA, Orazi A, Hasserjian R. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-2405.

2. Grinfeld J, Nangalia J, Baxter EJ. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med. 2018; 379(15):1416-1430.

3. Angona A, Fernández-Rodríguez C, Alvarez-Larrán A. Molecular characterisation of triple negative essential thrombocythaemia patients by platelets analysis and targeted sequencing. Blood Cancer J. 2016; 6(8):e463.

4. Michail O, McCallion P, McGimpsey J. Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort. J Clin Pathol. 2021; 74(12):808-811.

5. Acha P, Xandri M, Fuster-Tormo F. Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms. Am J Hematol. 2019; 94(10):E264-E267.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice;British Journal of Haematology;2024-07-14

2. Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements;Cancers;2024-01-25

3. Understanding triple negative myeloproliferative neoplasms: pathogenesis, clinical features, and management;Leukemia & Lymphoma;2023-11-30

4. Quantitative interpretation of bone marrow biopsies in MPN—What's the point in a molecular age?;British Journal of Haematology;2023-10-19

5. Identification of putative noncanonical driver mutations in patients with essential thrombocythemia;European Journal of Haematology;2023-03-14